Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
10.96
+1.80 (19.65%)
Feb 27, 2026, 10:40 AM EST - Market open
Relay Therapeutics Market Cap
Relay Therapeutics has a market cap or net worth of $1.96 billion as of February 27, 2026. Its market cap has increased by 191.84% in one year.
Market Cap
1.96B
Enterprise Value
1.12B
1-Year Change
191.84%
Ranking
Category
Stock Price
$10.96
Market Cap Chart
Since July 16, 2020, Relay Therapeutics's market cap has decreased from $3.03B to $1.96B, a decrease of -35.45%. That is a compound annual growth rate of -7.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 1.60B | 8.98% |
| Dec 31, 2025 | 1.47B | 112.63% |
| Dec 31, 2024 | 689.62M | -49.19% |
| Dec 29, 2023 | 1.36B | -24.86% |
| Dec 30, 2022 | 1.81B | -45.57% |
| Dec 31, 2021 | 3.32B | -11.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nurix Therapeutics | 1.66B |
| Intellia Therapeutics | 1.65B |
| MBX Biosciences | 1.65B |
| Ardelyx | 1.63B |
| Immunocore Holdings | 1.62B |
| Veradermics | 1.60B |
| Iovance Biotherapeutics | 1.56B |
| AnaptysBio | 1.55B |